Streetbeat News

Products Services

SFNC

Simmons Bank has opened a new branch in Cleveland, Tennessee, marking an expansion of its financial services in the area.

Portfolio Pulse from

December 11, 2024 | 7:45 pm

GOOG

Alphabet Inc (NASDAQ:GOOG) received a positive response from Bank of America after announcing a breakthrough quantum computing chip, Willow. The bank reiterated its 'Buy' rating, highlighting Alphabet's technological innovation and undervalued potential.

Portfolio Pulse from

December 11, 2024 | 7:45 pm

MDB

MongoDB, Inc. participated in the Barclays 22nd Annual Global Technology Conference, with key company figures such as President & CEO Dev Ittycheria and COO & CFO Michael Gordon present.

Portfolio Pulse from

December 11, 2024 | 7:45 pm

META

Meta has reported a 'technical issue' affecting users of its platforms Facebook, Instagram, and WhatsApp.

Portfolio Pulse from

December 11, 2024 | 7:30 pm

MET

MetLife and General Atlantic have partnered to launch Chariot Re, a new life and annuity reinsurance company, marking an expansion in the reinsurance sector.

Portfolio Pulse from

December 11, 2024 | 7:30 pm

IBKR

Interactive Brokers Chair Thomas Peterffy shared insights on a potential second Trump administration, the firm's growth prospects, and his cautious stance on cryptocurrencies during a Goldman Sachs conference.

Portfolio Pulse from

December 11, 2024 | 7:30 pm

STX

Seagate Technology Holdings plc participated in the Barclays 22nd Annual Global Technology Conference, with CFO Gianluca Romano representing the company.

Portfolio Pulse from

December 11, 2024 | 7:30 pm

TOL

Toll Brothers has announced the opening of a new model home at the Lakeside at Tessera community in Lago Vista, Texas. The model home highlights luxury single-family living with resort-style amenities on Lake Travis.

Portfolio Pulse from

December 11, 2024 | 7:30 pm

TTGT

Omdia forecasts a significant increase in global quantum computing vendor revenue by 2025, despite the current market being in its early stages with over 300 vendors primarily serving experimental customers.

Portfolio Pulse from

December 11, 2024 | 7:30 pm

CMRX

Chimerix, Inc.'s drug dordaviprone shows promise in treating H3 K27M-positive glioma, with potential FDA approval and commercial launch by Q3 2025. The company has strong clinical data and a cash runway of 6-7 quarters, but risks of dilution remain.

Portfolio Pulse from

December 11, 2024 | 7:30 pm